The weekly litigation news digest is live. Subscribe now

IP Verse

Cabazitaxel And Its Use For Treating Cancer - EP3294285

The patent EP3294285 was granted to Aventis Pharma on Dec 18, 2019. The application was filed on May 12, 2016 under application number EP16721844A. The patent is currently recorded with a legal status of "Revoked".

EP3294285

AVENTIS PHARMA
Application Number
EP16721844A
Filing Date
May 12, 2016
Status
Revoked
Dec 16, 2022
Publication Date
Dec 18, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (9)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
MEDAC GESELLSCHAFT FUR KLINISCHE SPEZIALPRAPARATESep 18, 2020UEXKULL & STOLBERGADMISSIBLE
ZENTIVASep 18, 2020GREINERADMISSIBLE
STADA ARZNEIMITTELSep 17, 2020HAMM & WITTKOPPADMISSIBLE
GENERICS UKSep 16, 2020TER MEER STEINMEISTER & PARTNERADMISSIBLE
DR REDDYS LABORATORIES BETAPHARM ARZNEIMITTELAug 26, 2020WUNSCHEADMISSIBLE
FRESENIUS KABI DEUTSCHLANDJul 9, 2020-ADMISSIBLE
HEXALJul 1, 2020MAIWALDADMISSIBLE
TEVA PHARMACEUTICALSJun 9, 2020LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBWITHDRAWN
ACCORD HEALTHCAREJun 3, 2020AERAADMISSIBLE

Patent Citations (6) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0817779
DESCRIPTIONUS5847170
DESCRIPTIONWO2005028462
DESCRIPTIONWO9630355
OPPOSITIONWO2011051894
OPPOSITIONWO2016180943

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents